Influence of follicular dendritic cells on HIV dynamics

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 355, Issue 1400, 2000, Pages 1051-1058

  Hlavacek, W S ^a   Stilianakis, N I ^a   Perelson, A S ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Antiretroviral therapy; Follicular dendritic cells; Human immunodeficiency virus type 1

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034730052     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2000.0642     Document Type: Article

References (49)

1. Virus dynamics and drug therapy
2. Follicular dendritic cells (FDC) in retroviral infection: Host/pathogen perspectives
3. Ritonavir and saquinavir combination therapy for the treatment of HIV infection
4. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
5. Latent reservoirs of HIV: Obstacles to the eradication of virus
6. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
7. Target cell limited and immune control models for HIV infection: A comparison
8. Viral dynamics in HIV-1 infection
9. Why is it so hard to dissociate multivalent antigens from cell-surface antibodies?
10. + T cell demographics and dynamics in lymphatic tissues
11. Quantitative image analysis of HIV-1 infection in lymphoid tissue
12. Follicular dendritic cells and human immunodeficiency virus infectivity
13. Dissociation of HIV-1 from follicular dendritic cells during HAART: Mathematical analysis
14. Influence of follicular dendritic cells on decay of HIV type 1 during antiretroviral therapy
15. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma
16. Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent
17. Extracellular water: Sodium bromide dilution estimates compared with other markers in patients with acquired immunodeficiency syndrome
18. Control of the complement system
19. Follicular dendritic cells specifically express the long CR2/CD21 isoform
20. Population dynamics of HIV within an individual after treatment with zidovudine
21. The follicular dendritic cell: Long term antigen retention during immunity
22. Comparison of methods for assessing nutritional status in HIV-infected adults
23. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine
24. Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen
25. Population dynamics of immune responses to persistent viruses
26. Lymph node architecture preceding and following 6 months of potent antiviral therapy: Follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient
27. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection
28. Receptor clustering on a cell surface. III. Theory of receptor cross-linking by multivalent ligands: Description by ligand states
29. Some mathematical models of receptor clustering by multivalent ligands
30. Mathematical analysis of HIV-1 dynamics in vivo
31. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
32. Decay characterisitics of HIV-1-infected compartments during combination therapy
33. + lymphocytes in vivo
34. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
35. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens
36. Membrane complement receptors specific for bound fragments of C3
37. + T lymphocytes in HIV-1 infection as measured by Ki-67 antigen
38. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timing of antiretroviral therapy
39. Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia
40. + T cells
41. Role of complement in HIV infection
42. A novel in vivo follicular dendritic cell-dependent iccosome-mediated mechanism for delivery of antigen to antigen-processing cells
43. The unenlarged lymph nodes of HIV-1 infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy
44. General analysis of receptor-mediated viral attachment to cell surfaces
45. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure
46. Complement activation in the follicular light zone of human lymphoid tissues
47. + T cell repopulation of lymphoid tissues after treatment of HIV-1 infection
48. Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques
49. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection